providers.genedx.com Open in urlscan Pro
2606:4700:10::6816:a13  Public Scan

URL: https://providers.genedx.com/
Submission: On March 08 via manual from US — Scanned from DE

Form analysis 1 forms found in the DOM

/search

<form id="header-mobile-search-form" style="display: none;" action="/search">
  <input type="hidden" name="searchType" value="Resources">
  <input class="form-control" type="search" aria-label="Search" placeholder="Search" name="term">
</form>

Text Content

 * Login
 * Request Supplies
 * Custom Slice tool
 * Contact
 * Order a Test
 * 0

 * Request Supplies
 * Custom Slice tool
 * 
 * Contact
 * Order a Test
 * 


DISEASE SHOULD BE RARE. DIAGNOSIS SHOULDN'T.

That’s the future we’re building at GeneDx.

About us



WE PROVIDE ANSWERS, SO YOU CAN FOCUS ON CARE


Find the right diagnosis the first time.
Whole genome and exome testing offer a complete view of a patient’s genetic
makeup and have a superior diagnostic yield to multi-gene panels. Additionally,
more and more professional society guidelines support exome and genome testing
as a first line test, particularly for epilepsy, intellectual
disability/developmental delay, and congenital abnormalities. Starting complex
disease patients with genome or exome testing means getting them to a diagnosis
faster and saving patients and families years of unnecessary testing, heartache,
and stress.

More accurate information means more effective treatment plans.
Our unique ability to analyze genomic information alongside comprehensive
clinical datasets means patients are provided with an incredibly precise
diagnosis.This enables patients to get the exact care they need, including
connecting them to appropriate clinical trials or developing specialized care
plans.

Science backed by support.
We are here for you and your patients throughout the entire testing process,
from placing orders to interpreting results. Our dedicated team of genetic
counselors provides peer-to-peer support as well as pre- and post-test
counseling services. Also, our billing experts work with families on flexible
and affordable payment plans so patients can get the care they need. With
comprehensive care from start to finish, we offer more than just a test result.

Explore our offerings

--------------------------------------------------------------------------------

 


ONE TEST. BIG PICTURE. BRIGHTER FUTURES.

Our mission is to deliver personalized and actionable health insights to inform
diagnosis, direct treatment, and improve drug discovery.

 

 

At GeneDx, we believe that everyone deserves personalized, targeted medical
care—and that it all begins with a genetic diagnosis.

Fueled by one of the world's largest rare disease data sets, our
industry-leading exome and genome tests translate complex genomic data into
clinical answers.

Our state-of-the-art interpretation platform, paired with our robust data set,
make us the go-to lab when doctors need diagnoses for children with both rare
diseases and common conditions.

--------------------------------------------------------------------------------

 


LATEST NEWS

GeneDx to Participate in 44th Annual Cowen Health Care Conference
February 26, 2024

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through
genomic and clinical insights, today announced that company management will
participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA.

READ MORE
 

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues
Guidance for Full Year 2024
February 20, 2024

GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health
outcomes through genomic and clinical insights, today reported its financial
results for the fourth quarter and full year of 2023.

READ MORE
 

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20,
2024
February 1, 2024

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through
genomic and clinical insights, today announced it will release financial results
for the fourth quarter of 2023 after the market closes on Tuesday, February 20,
2024.

READ MORE
 

 * 
 * 
 * 
 * 
 * 

© 2024 GeneDx, LLC


Unexpected error
Unexpected error has happened. We cannot automatically resolve it. Sorry for
inconvenience.Try one of actions below. If you choose to stay on the page you
won't be able to perform any other operation.
Stay on the pageRefresh the pageLogout